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Abstract
Objective: The present study was done to find out the frequency of malignant tumors of bone and to
categorize the prevelence of various histological types of osseous malignancies with respect to age, sex
and site of origin.
Setting: This study included consecutive cases of malignant bone tumors, which were diagnosed in the
department of pathology at the Aga Khan University Hospital, Karachi during the period of three years
(1995-1997).
Methods: These tumors were initially evaluated on H & E stained section from paraffin embedded
tissue blocks. Special stains and immunohistochemical analysis was performed whenever required.
Results: A total of 169 malignant bone tumors were diagnosed during the study period. Metastatic
tumors accounted for 28.4% of all malignant tumors of bone. Osteogenic sarcoma (27.2%) was the
most frequent primary tumor of bone followed by Ewing’s sarcoma (12.4%), Non- Hodgkin’s
lymphoma (10.6%), Chondrosarcoma (8.3%), Plasma Cell Myeloma (8.3%) and other rare entities
(4.8%) in order of frequency.
Conclusion: The most common malignant neoplasm diagnosed in osseous biopsies was metastatic
tumors. Osteogenic sarcoma was the most frequent primary bone tumor in this series. The bone tumors
were relatively more prevalent in males. The frequency of malignant bone tumor was relatively high as
compared to developed countries UPMA 49:110, 1999).
Introduction
Marked variation in the prevalence rate of malignant tumors of bones has been observed in the different
regions of the world. In developed countries, bone tumors are quite infrequent1,2, while in developing
countries, the prevalence of bone cancer is relatively high3-5. In Pakistan, a relatively high frequency of
bone tumors has been observed in the northern region as compared to southern part of the country6-9.
Environmental, genetic and racial factors influence the geographical distribution of cancer10. Data
about the cancer from the different regions of the world helps to find out the various associated factors,
which could provide clues regarding the identification of the cause of disease”. The aims and objectives
of the present study were to find the frequency of malignant tumors of bone and to categorize the
prevalence of various histological types of osseous malignancies with respect to age, sex and site of
origin.
Materials and Methods
This study included consecutive cases of malignant bone tumors, which were diagnosed in the
department of pathology at the Aga Khan University Hospital, Karachi during the period of three years
(1995-1997). These tumors were initially evaluated on Haematoxylin & Eosin stained sections of
paraffin embedded 10% buffered formalin fixed tissue blocks. Special stains like peroxidase acid schiff
(PAS), peroxidase acid schiff with diastase (PASD), Reticulin, PAS Alcian blue and PAS Alcian blue
with diastase were performed whenever required. The immunohistochem ical staining with

Cytokeratins, Leukocyte Common Antigen (LCA), PAN B (CD 20, L26), PAN T (UCHL 1), Vimentin,
Neuron Specific Enolase (NSE), Neurofilament and S-100 protein was done by using PeroxidaseAntiperoxidase (PAP) technique whenever indicated. Clinical details like age, sex and site of the lesion
were also recorded.
Results
A total of 8541 malignant tumors were diagnosed in the period of three years (1995-1997), which
included 169 (2%) malignant tumors of bone. The most common malignant neoplasm diagnosed in
osseous biopsies was metastases, which constituted 28.4% of all malignant tumors of bone. Osteogenic
sarcoma (27.2%) was the most frequent primary tumor of bone, followed by Ewing’s sarcoma (12.4%),
Non Hodgkin’s lymphoma (10.6%), Chondrosarcoma (8.3%) and plasma cell myeloma (8.3%) in order
of frequency. Rare entities like primitive neuroectodermal tumor (PNET), chordoma and malignant
fibrous histiocytoma constituted 4.8% of all bone tumors (Table 1).

Metastatic tumors were seen in adults with male to female ratio of 1.3:1. The mean age was 60 years in
males and 55 years in females. Osteogenic sarcoma was slightly more common in female with male to
female ratio of 1:1.09. A significant number (4 1%) of these tumors were seen in children below the age
of 15 years. The mean age was 19 years for males and 15.6 years for females in the cases of ostegenic
sarcoma. In about three fourth cases, osteogenic sarcoma was around the knee joint. This tumor most

frequently involved the femur (55.2%) followed by tibia (20.6%) and humerus (17.2%). The other less
frequent sites (7%) included hip bone, radius and ulna. Ewing’s sarcoma was the second most common
primary malignant tumor of the bone with male to female ratio of 1.6:1. Majority of these tumors
(57%) occurred in children under the age of 15 years. The mean age was 13.3 years in males and 12.8
years in females in the cases of Ewing’s sarcoma. Chondrosarcoma most frequently occurred in adults
with male to female ratio of 2.5:1. The mean age was 39.2 years in males and 5.1.2 years in females. In
Non-Hodgkin’s lymphoma cases the male to female ratio was 3.5:1. The mean age was 35.5 years in
males and 21.2 years in females. In plasma cell myeloma, the male to female ratio was 1: 1. The mean
age was 58 years in males as well as in females (Table 2).

Discussion
Cancer is one of the leading cause of death in the developed countries but the morbidity and mortality
caused by malignant disorders is becoming an increasingly serious problem in the developing countries
as well. In absolute numbers, there are more cases and increased mortality due to malignant neoplastic

lesions in the developing countries as compared to developed nations10.
The prevention and control of cancer requires the identification of agents and circumstances, which are
the cause of the disease. The study of variation in the frequency and patterns of cancer in different
regions can provide clues about the causes and risk factors. The change in the prevalence rate of the
disease in a region over a period of time, provides valuable information about the presence of
preventable predisposing factors.
The frequency of malignant bone tumors varies from 0.2% to 5.1% in the different regions of the
world1-8. The prevalence of bone cancer is low in the Western countries as compared to the developing
nations. The relatively higher frequency of malignant bone tumor in developing countries could be
attributed to the relatively increased population of children as approximately thirty nine percent (39%)
of the population of developing countries comprises of children under the age of 15 years12. While in
western countries the paediatric age group constitutes 23% of the total population12. Primary tumors of
bone are more common in young age groups13. This may be one reason for the increased frequency of
bone tumors in developing countries.
In our series, the bone tumors comprised 2% of all malignant neoplasms. Primary bone tumors were
3.14% of all tumors in a series from northern region of Pakistan9. The difference would be even greater
because the present study included the metastatic tumors also. The bone tumors were relatively more
prevalent in males with male to female ratio of 1.3:1. High male to female ratio has been observed in
other types of malignant tumors as wel15-8,14. According to western literature, cancer used to be more
common in females in the past but now it is relatively more frequent in males3.
In the present study, metastatic tumor (28.4%) was the most common category of cancer diagnosed in
the osseous biopsies. The increased prevalence of metstatic tumors in bones could be due to late
presentation of patients or lack of appropriate diagnostic and treatment facilities.
Osteogenic sarcoma was the most common primary bone tumor in our series, which is in accordance
with the previous published series9. In the present study, osteogenic sarcoma was slightly more
frequent in females with male to female ratio of 1:1.08. But in the other series, osteogenic sarcoma was
more common in males with male to female ratio of 3.3:1g.
In this study, Ewing’s sarcoma (12.4%) was more prevalent as compared to chondrosarcoma (8.3%)
and plasma cell myeloma (8.3%). A published series from AFIP Rawalpindi revealed that
chondrosarcoma (22.1%) and Plasma cell myeloma (15%) were more common as compared to Ewing’s
sarcoma (8.6%)9. In Ewing’s sarcoma, the mean age was 13.3 years for males and 12.8 years for
females and it was less than the mean age reported in the earlier published series9,15. The age of the
patient has got prognostic significance as well. The response rate to the treatment decreases with
increase in age in the cases of Ewing’s sarcoma16,17.
An elevated risk of bone cancer has been reported in children whose fathers were employed in
agricultural occupation12,18. The high prevalence of bone tumors in developing countries may be
attributed to the parental occupation. A significant proportion of the population of the developing
countries is associated with agriculture as compared to the industrialised nations. In this regard, further
studies in the developing countries would be helpful.
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